A Phase II Study of Depsipeptide (NSC-630176) [romidepsin] In Patients With Advanced Transitional Cell Carcinoma Of The Urinary Tract Who Have Progressed After Receiving One Prior Chemotherapy Regimen For Advanced Disease
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2012
At a glance
- Drugs Romidepsin (Primary)
- Indications Bladder cancer; Urogenital cancer
- Focus Therapeutic Use
- 09 Jun 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 24 Aug 2005 New trial record.